Treatment of type 2 diabetes with fty720

• 收藏
• 分享

专利权人:

ZHONGMIN MA

发明人:

MA ZHONGMIN

申请号：

NZ62002512

公开号：

NZ620025A

申请日:

2012.08.03

申请国别(地区):

NZ

年份:

2016

代理人:

摘要：

Disclosed is the use of the sphingosine-1-phosphate receptor modulator 2-amino-2-(hydroxymethyl)-4-(4-octylphenyl)butyl dihydrogen phosphate (FTY720/Fingolimod/Gilenya) and FTY720-P (Fingolimod-phosphate) for prevention and treatment of type-2 diabetes. The compounds, which are FDA approved drugs for treating multiple sclerosis, are demonstrated to normalize fasting glucose levels.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/